JP2014504500A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014504500A5 JP2014504500A5 JP2013546722A JP2013546722A JP2014504500A5 JP 2014504500 A5 JP2014504500 A5 JP 2014504500A5 JP 2013546722 A JP2013546722 A JP 2013546722A JP 2013546722 A JP2013546722 A JP 2013546722A JP 2014504500 A5 JP2014504500 A5 JP 2014504500A5
- Authority
- JP
- Japan
- Prior art keywords
- expression system
- virus
- protein
- polynucleotide
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2010/007995 WO2012089231A1 (en) | 2010-12-30 | 2010-12-30 | Paramyxovirus vaccines |
| EPPCT/EP2010/007995 | 2010-12-30 | ||
| PCT/EP2011/074307 WO2012089833A2 (en) | 2010-12-30 | 2011-12-30 | Expression Systems |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017004556A Division JP2017079787A (ja) | 2010-12-30 | 2017-01-13 | 発現系 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014504500A JP2014504500A (ja) | 2014-02-24 |
| JP2014504500A5 true JP2014504500A5 (enExample) | 2015-02-19 |
| JP6324725B2 JP6324725B2 (ja) | 2018-05-16 |
Family
ID=45464575
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013546722A Expired - Fee Related JP6324725B2 (ja) | 2010-12-30 | 2011-12-30 | 発現系 |
| JP2017004556A Pending JP2017079787A (ja) | 2010-12-30 | 2017-01-13 | 発現系 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017004556A Pending JP2017079787A (ja) | 2010-12-30 | 2017-01-13 | 発現系 |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US20140141042A1 (enExample) |
| EP (2) | EP2658573B1 (enExample) |
| JP (2) | JP6324725B2 (enExample) |
| KR (1) | KR102070463B1 (enExample) |
| CN (1) | CN103442731B (enExample) |
| AU (2) | AU2011351380A1 (enExample) |
| BR (1) | BR112013016823A2 (enExample) |
| CA (1) | CA2821111A1 (enExample) |
| CY (1) | CY1124146T1 (enExample) |
| DK (1) | DK2658573T3 (enExample) |
| ES (1) | ES2869199T3 (enExample) |
| HR (1) | HRP20210750T1 (enExample) |
| HU (1) | HUE053986T2 (enExample) |
| IL (1) | IL226551B (enExample) |
| LT (1) | LT2658573T (enExample) |
| MX (1) | MX352205B (enExample) |
| NZ (1) | NZ610743A (enExample) |
| PL (1) | PL2658573T3 (enExample) |
| PT (1) | PT2658573T (enExample) |
| RU (1) | RU2609645C2 (enExample) |
| SG (2) | SG190919A1 (enExample) |
| SI (1) | SI2658573T1 (enExample) |
| WO (2) | WO2012089231A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2869841T3 (pl) | 2012-07-05 | 2022-01-24 | Glaxosmithkline Biologicals Sa | Nowe schematy prime-boost wykorzystujące polipeptydy immunogenne kodowane przez polinukleotydy |
| BR112015002131B1 (pt) | 2012-08-01 | 2022-11-01 | Bavarian Nordic A/S | Vírus vaccinia ankara modificado (mva) recombinante, composição farmacêutica e uso do referido mva recombinante |
| UA123385C2 (uk) * | 2012-08-01 | 2021-03-31 | Баваріан Нордік А/С | Рекомбінантний модифікований вірус вісповакцини анкара (mva) та спосіб лікування або попередження інфекцій вірусу rsv |
| WO2014024026A1 (en) | 2012-08-06 | 2014-02-13 | Glaxosmithkline Biologicals S.A. | Method for eliciting in infants an immune response against rsv and b. pertussis |
| US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
| US10016496B2 (en) * | 2013-02-01 | 2018-07-10 | Medimmune, Llc | Respiratory syncytial virus F protein epitopes |
| US20140286981A1 (en) * | 2013-03-14 | 2014-09-25 | Wisconsin Alumni Research Foundation | Broadly reactive mosaic peptide for influenza vaccine |
| EP3653701A1 (en) | 2013-03-15 | 2020-05-20 | The Research Foundation for The State University of New York | Attenuated influenza viruses and vaccines |
| KR20160040290A (ko) | 2013-08-05 | 2016-04-12 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 조합 면역원성 조성물 |
| CA2951430A1 (en) * | 2014-06-13 | 2015-12-17 | Glaxosmithkline Biologicals Sa | Immunogenic combinations |
| JP6983665B2 (ja) | 2015-06-12 | 2021-12-17 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | アデノウイルスポリヌクレオチド及びポリペプチド |
| MA47016A (fr) * | 2015-10-22 | 2018-08-29 | Modernatx Inc | Vaccins contre les virus respiratoires |
| GB201614485D0 (en) | 2016-08-25 | 2016-10-12 | Univ Oxford Innovation Ltd | Immunogenic composition |
| EP3518966A1 (en) | 2016-09-29 | 2019-08-07 | GlaxoSmithKline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| MA50335A (fr) | 2016-12-08 | 2020-08-19 | Modernatx Inc | Vaccins à acide nucléique contre des virus respiratoires |
| GB201620968D0 (en) | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
| CA3045976A1 (en) | 2016-12-09 | 2018-06-14 | Glaxosmithkline Biologicals Sa | Chimpanzee adenovirus constructs with lyssavirus antigens |
| GB201701239D0 (en) | 2017-01-25 | 2017-03-08 | Glaxosmithkline Biologicals Sa | Novel formulation |
| CN107119064A (zh) * | 2017-02-21 | 2017-09-01 | 南京农业大学 | 重组枯草芽孢杆菌串联表达禽流感病毒ha抗原片段和pb1－f2蛋白 |
| EP3697902A1 (en) | 2017-10-16 | 2020-08-26 | GlaxoSmithKline Biologicals S.A. | Enhanced promoter |
| ES3056141T3 (en) | 2017-10-16 | 2026-02-18 | Glaxosmithkline Biologicals Sa | Simian adenoviral vectors with two expression cassettes |
| BR112020007008A2 (pt) | 2017-10-16 | 2020-11-17 | Glaxosmithkline Biologicals S.A. | vetores adenovirais com dois cassetes de expressão codificando proteínas antigênicas do rsv ou fragmentos das mesmas |
| SG11202003609VA (en) * | 2017-10-25 | 2020-05-28 | Nouscom Ag | Eukaryotic cell line |
| CA3085975A1 (en) | 2017-12-20 | 2019-06-27 | Glaxosmithkline Biologicals Sa | Epstein-barr virus antigen constructs |
| BR112020024285A2 (pt) | 2018-06-12 | 2021-03-02 | Glaxosmithkline Biologicals S.A. | polinucleotídeos e polipeptídeos de adenovírus |
| CA3106400A1 (en) | 2018-07-13 | 2020-01-16 | University Of Georgia Research Foundation | Broadly reactive immunogens of influenza h3 virus, compositions and methods of use thereof |
| CN109180820B (zh) * | 2018-09-19 | 2021-06-25 | 天康生物制药有限公司 | 马流感病毒h3n8亚型的融合蛋白及其制备方法、应用和疫苗 |
| WO2020061443A2 (en) * | 2018-09-21 | 2020-03-26 | Board Of Regents Of The University Of Nebraska | Methods of making and using universal centralized influenza vaccine genes |
| US11351242B1 (en) | 2019-02-12 | 2022-06-07 | Modernatx, Inc. | HMPV/hPIV3 mRNA vaccine composition |
| CN112220921B (zh) * | 2020-08-25 | 2022-08-16 | 北京交通大学 | 一种针对呼吸道合胞病毒感染的组合疫苗 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7135312B2 (en) * | 1993-04-15 | 2006-11-14 | University Of Rochester | Circular DNA vectors for synthesis of RNA and DNA |
| DE19651443A1 (de) * | 1996-12-11 | 1998-06-18 | Hoechst Ag | Selbstverstärkende, pharmakologisch kontrollierbare Expressionssysteme |
| US7655774B2 (en) | 2000-02-18 | 2010-02-02 | University Of Washington | Ancestral and COT viral sequences, proteins and immunogenic compositions |
| CN100333792C (zh) | 2001-09-28 | 2007-08-29 | 南佛罗里达大学 | Rsv基因表达疫苗 |
| HU230364B1 (hu) * | 2001-11-21 | 2016-03-29 | The Trustees Of The University Of Pennsylvania | Simian adenovírus nukleinsav és aminosav-szekvencia, azt tartalmazó vektorok, és eljárások annak alkalmazására |
| CA2743750A1 (en) * | 2002-02-21 | 2003-09-04 | Medimmune, Llc | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus |
| AU2003256823B9 (en) * | 2002-07-25 | 2009-01-08 | Medimmune, Llc | Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies |
| US20050136035A1 (en) * | 2003-06-03 | 2005-06-23 | Derek Ko | Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| US7566458B2 (en) * | 2003-06-16 | 2009-07-28 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
| DK1711518T3 (da) | 2004-01-23 | 2010-04-06 | Angeletti P Ist Richerche Bio | Vaccinebærere for chimpanse-adenovirus |
| WO2007126887A2 (en) * | 2006-03-27 | 2007-11-08 | The Government Of The United States Of America | Immunogenic compositions comprising polynucleotides encoding matrix protein 2 and methods of use |
| WO2008054540A2 (en) * | 2006-05-18 | 2008-05-08 | Pharmexa Inc. | Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
| JP6199533B2 (ja) * | 2006-07-13 | 2017-09-20 | インスティチュート フォー アドバンスド スタディ | ウイルス阻害性ヌクレオチド配列およびワクチン |
| WO2008028759A1 (de) | 2006-09-05 | 2008-03-13 | BSH Bosch und Siemens Hausgeräte GmbH | Bodendüse für hartböden |
| US8772256B2 (en) * | 2006-11-30 | 2014-07-08 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Codon modified immunogenic compositions and methods of use |
| WO2009092113A2 (en) * | 2008-01-19 | 2009-07-23 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for the delivery of vaccines to disrupted epithelium |
| US20100040650A1 (en) * | 2008-05-30 | 2010-02-18 | Crowe Jr James E | Virus-Like paramyxovirus particles and vaccines |
| JP2011521985A (ja) * | 2008-06-03 | 2011-07-28 | オカイロス アーゲー | Ｈｃｖ感染の予防および治療のためのワクチン |
| CA2730737A1 (en) * | 2008-07-15 | 2010-01-21 | Novartis Ag | Immunogenic amphipathic peptide compositions |
| WO2010077717A1 (en) * | 2008-12-09 | 2010-07-08 | Novavax, Inc. | Modified rsv f proteins and methods of their use |
| WO2010077712A1 (en) * | 2008-12-09 | 2010-07-08 | Novavax, Inc. | Bovine respiratory syncytial virus virus-like particle (vlps) |
| JP2010168288A (ja) * | 2009-01-20 | 2010-08-05 | Yokohama City Univ | 最適化した抗原遺伝子の使用によるウイルスワクチンの免疫原性の増強 |
| AU2010209938A1 (en) | 2009-02-02 | 2011-08-25 | Glaxosmithkline Biologicals Sa | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
-
2010
- 2010-12-30 WO PCT/EP2010/007995 patent/WO2012089231A1/en not_active Ceased
-
2011
- 2011-12-30 HU HUE11805889A patent/HUE053986T2/hu unknown
- 2011-12-30 US US13/976,873 patent/US20140141042A1/en not_active Abandoned
- 2011-12-30 PL PL11805889T patent/PL2658573T3/pl unknown
- 2011-12-30 MX MX2013007716A patent/MX352205B/es active IP Right Grant
- 2011-12-30 WO PCT/EP2011/074307 patent/WO2012089833A2/en not_active Ceased
- 2011-12-30 HR HRP20210750TT patent/HRP20210750T1/hr unknown
- 2011-12-30 BR BR112013016823A patent/BR112013016823A2/pt not_active IP Right Cessation
- 2011-12-30 SG SG2013041348A patent/SG190919A1/en unknown
- 2011-12-30 RU RU2013135498A patent/RU2609645C2/ru active
- 2011-12-30 NZ NZ610743A patent/NZ610743A/en not_active IP Right Cessation
- 2011-12-30 PT PT118058890T patent/PT2658573T/pt unknown
- 2011-12-30 AU AU2011351380A patent/AU2011351380A1/en not_active Abandoned
- 2011-12-30 KR KR1020137017082A patent/KR102070463B1/ko not_active Expired - Fee Related
- 2011-12-30 SI SI201131973T patent/SI2658573T1/sl unknown
- 2011-12-30 SG SG10201510760WA patent/SG10201510760WA/en unknown
- 2011-12-30 DK DK11805889.0T patent/DK2658573T3/da active
- 2011-12-30 CA CA2821111A patent/CA2821111A1/en active Pending
- 2011-12-30 CN CN201180063466.0A patent/CN103442731B/zh not_active Expired - Fee Related
- 2011-12-30 EP EP11805889.0A patent/EP2658573B1/en active Active
- 2011-12-30 LT LTEP11805889.0T patent/LT2658573T/lt unknown
- 2011-12-30 EP EP21158524.5A patent/EP3868397A1/en not_active Withdrawn
- 2011-12-30 ES ES11805889T patent/ES2869199T3/es active Active
- 2011-12-30 JP JP2013546722A patent/JP6324725B2/ja not_active Expired - Fee Related
-
2013
- 2013-05-23 IL IL226551A patent/IL226551B/en active IP Right Grant
-
2016
- 2016-03-11 US US15/068,115 patent/US20170049879A1/en not_active Abandoned
-
2017
- 2017-01-13 JP JP2017004556A patent/JP2017079787A/ja active Pending
- 2017-05-12 AU AU2017203189A patent/AU2017203189B2/en not_active Ceased
-
2020
- 2020-02-25 US US16/800,384 patent/US11701422B2/en active Active
-
2021
- 2021-05-17 CY CY20211100421T patent/CY1124146T1/el unknown
-
2023
- 2023-05-22 US US18/200,421 patent/US20240075125A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014504500A5 (enExample) | ||
| RU2013135498A (ru) | Экспрессионные системы | |
| Cheung et al. | Biology of influenza a virus | |
| US12364746B2 (en) | Mosaic influenza virus hemagglutinin polypeptides and uses thereof | |
| Bouvier et al. | The biology of influenza viruses | |
| Labadie et al. | Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells | |
| Cauldwell et al. | Viral determinants of influenza A virus host range | |
| CA2805505C (en) | Chimeric influenza viruses having reduced ability to reassort with other influenza viruses and uses thereof | |
| JP2015506689A5 (enExample) | ||
| CA2848117A1 (en) | Recombinant influenza virus highly expressing ha protein and preparation method and use thereof | |
| AR076690A1 (es) | Vacuna universal contra la influenza basada en un virus vaccinia ankara modificado (mva) recombinante | |
| IL321503A (en) | Recombinant virus, composition comprising the same, and uses thereof | |
| Urbaniak et al. | In vivo reassortment of influenza viruses | |
| JP2019500860A5 (enExample) | ||
| JP6335167B2 (ja) | 感染性インフルエンザウイルスの産生 | |
| RU2013150802A (ru) | Способы выделения и определения количественного содержания антигена в вакцинах | |
| Wang et al. | PA from an H5N1 highly pathogenic avian influenza virus activates viral transcription and replication and induces apoptosis and interferon expression at an early stage of infection | |
| Timofeeva et al. | Mutations in the genome of avian influenza viruses of the H1 and H5 subtypes responsible for adaptation to mammals | |
| JP2017531032A (ja) | ワクチン抗原の製造方法、得られるワクチン抗原、および使用 | |
| Kwon et al. | Characterization of a chicken embryo-adapted H9N2 subtype avian influenza virus | |
| Tsuda et al. | Factors responsible for plaque formation of A/duck/Siberia/272/1998 (H13N6) influenza virus on MDCK cells | |
| Hartgroves et al. | Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs | |
| Lee et al. | Control technique of avian influenza | |
| Lee et al. | Complete genome sequence of a natural recombinant H9N2 influenza virus from wild birds in Republic of Korea | |
| Wang et al. | Complete genome sequences of six avian-like H1N1 swine influenza viruses from northwestern China |